Back to state act
Description
On 16 March 2021, Canadian biotechnology company, Immune Biosolutions announced securing CAD 13.44 million (USD 10.8 million) from the government to develop and manufacture its immunotherapy to treat ...
Sign in to see full description
Intervention Details
Intervention Type
State loan
MAST Chapter
L: Subsidies (excl. export subsidies)
Implementation date
16 Mar 2021
Revocation date
No revocation date
Implementation level
National
Affected flow
Inward
Announced as temporary
No
Eligible firms
firm-specific
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 20 products
Threads
See all
This intervention is not part of any Thread yet.